DR5-mediated DISC controls caspase-8 cleavage and initiation of apoptosis in human glioblastomas

Anita Bellail, Margaret C.L. Tse, Jin H. Song, Surasak Phuphanich, Jeffrey J. Olson, Shi Yong Sun, Chunhai Hao

Research output: Contribution to journalArticle

59 Citations (Scopus)

Abstract

To explore the molecular mechanisms by which glioblastomas are resistant to tumour necrosis factor-related apoptosis-inducing ligand (TRAIL), we examined TRAIL signalling pathways in the tumours. TRAIL has four membrane-anchored receptors, death receptor 4/5 (DR4/5) and decoy receptor 1/2 (DcR1/2). Of these receptors, only DR5 was expressed consistently in glioblastoma cell lines and tumour tissues, ruling out the role of DcR1/2 in TRAIL resistance. Upon TRAIL binding, DR5 was homotrimerized and recruited Fas-associated death domain (FADD) and caspase-8 for the assembly of death-inducing signalling complex (DISC) in the lipid rafts of the plasma membrane. In the DISC, caspase-8 was cleaved and initiated apoptosis by cleaving downstream caspases in TRAIL-sensitive glioblastoma cells. In TRAIL-resistant cells, however, DR5-mediated DISC was modified by receptor-interacting protein (RIP), cellular FADD-like interleukin-1β-converting enzyme inhibitory protein (c-FLIP) and phosphoprotein enriched in diabetes or in astrocyte-15 (PED/PEA-15). This DISC modification occurred in the non-raft fractions of the plasma membrane and resulted in the inhibition of caspase-8 cleavage and activation of nuclear factor-κB (NF-κB). Treatment of resistant cells with parthenolide, an inhibitor of inhibitor of κB (I-κB), eliminated TRAIL-induced NF-κB activity but not TRAIL resistance. In contrast, however, targeting of RIP, c-FLIP or PED/PEA-15 with small interfering RNA (siRNA) led to the redistribution of the DISC from non-rafts to lipid rafts and eliminated the inhibition of caspase-8 cleavage and thereby TRAIL resistance. Taken together, this study indicates that the DISC modification by RIP, c-FLIP and PED/PEA-15 is the most upstream event in TRAIL resistance in glioblastomas.

Original languageEnglish (US)
Pages (from-to)1303-1317
Number of pages15
JournalJournal of Cellular and Molecular Medicine
Volume14
Issue number6 A
DOIs
StatePublished - Jun 1 2010
Externally publishedYes

Fingerprint

Death Domain Receptor Signaling Adaptor Proteins
Caspase 8
Glioblastoma
Receptor-Interacting Protein Serine-Threonine Kinases
TNF-Related Apoptosis-Inducing Ligand Receptors
Apoptosis
Cell Membrane
Lipids
Caspase 1
Phosphoproteins
Caspases
Tumor Cell Line
Astrocytes
Small Interfering RNA
Tumor Necrosis Factor-alpha
Ligands
Membranes

Keywords

  • Apoptosis
  • Caspase-8
  • DR5
  • Glioblastoma
  • TRAIL

ASJC Scopus subject areas

  • Molecular Medicine
  • Cell Biology

Cite this

DR5-mediated DISC controls caspase-8 cleavage and initiation of apoptosis in human glioblastomas. / Bellail, Anita; Tse, Margaret C.L.; Song, Jin H.; Phuphanich, Surasak; Olson, Jeffrey J.; Sun, Shi Yong; Hao, Chunhai.

In: Journal of Cellular and Molecular Medicine, Vol. 14, No. 6 A, 01.06.2010, p. 1303-1317.

Research output: Contribution to journalArticle

Bellail, Anita ; Tse, Margaret C.L. ; Song, Jin H. ; Phuphanich, Surasak ; Olson, Jeffrey J. ; Sun, Shi Yong ; Hao, Chunhai. / DR5-mediated DISC controls caspase-8 cleavage and initiation of apoptosis in human glioblastomas. In: Journal of Cellular and Molecular Medicine. 2010 ; Vol. 14, No. 6 A. pp. 1303-1317.
@article{c6399a5a759a426bb1aa9473cf2944f2,
title = "DR5-mediated DISC controls caspase-8 cleavage and initiation of apoptosis in human glioblastomas",
abstract = "To explore the molecular mechanisms by which glioblastomas are resistant to tumour necrosis factor-related apoptosis-inducing ligand (TRAIL), we examined TRAIL signalling pathways in the tumours. TRAIL has four membrane-anchored receptors, death receptor 4/5 (DR4/5) and decoy receptor 1/2 (DcR1/2). Of these receptors, only DR5 was expressed consistently in glioblastoma cell lines and tumour tissues, ruling out the role of DcR1/2 in TRAIL resistance. Upon TRAIL binding, DR5 was homotrimerized and recruited Fas-associated death domain (FADD) and caspase-8 for the assembly of death-inducing signalling complex (DISC) in the lipid rafts of the plasma membrane. In the DISC, caspase-8 was cleaved and initiated apoptosis by cleaving downstream caspases in TRAIL-sensitive glioblastoma cells. In TRAIL-resistant cells, however, DR5-mediated DISC was modified by receptor-interacting protein (RIP), cellular FADD-like interleukin-1β-converting enzyme inhibitory protein (c-FLIP) and phosphoprotein enriched in diabetes or in astrocyte-15 (PED/PEA-15). This DISC modification occurred in the non-raft fractions of the plasma membrane and resulted in the inhibition of caspase-8 cleavage and activation of nuclear factor-κB (NF-κB). Treatment of resistant cells with parthenolide, an inhibitor of inhibitor of κB (I-κB), eliminated TRAIL-induced NF-κB activity but not TRAIL resistance. In contrast, however, targeting of RIP, c-FLIP or PED/PEA-15 with small interfering RNA (siRNA) led to the redistribution of the DISC from non-rafts to lipid rafts and eliminated the inhibition of caspase-8 cleavage and thereby TRAIL resistance. Taken together, this study indicates that the DISC modification by RIP, c-FLIP and PED/PEA-15 is the most upstream event in TRAIL resistance in glioblastomas.",
keywords = "Apoptosis, Caspase-8, DR5, Glioblastoma, TRAIL",
author = "Anita Bellail and Tse, {Margaret C.L.} and Song, {Jin H.} and Surasak Phuphanich and Olson, {Jeffrey J.} and Sun, {Shi Yong} and Chunhai Hao",
year = "2010",
month = "6",
day = "1",
doi = "10.1111/j.1582-4934.2009.00777.x",
language = "English (US)",
volume = "14",
pages = "1303--1317",
journal = "Journal of Cellular and Molecular Medicine",
issn = "1582-1838",
publisher = "Wiley-Blackwell",
number = "6 A",

}

TY - JOUR

T1 - DR5-mediated DISC controls caspase-8 cleavage and initiation of apoptosis in human glioblastomas

AU - Bellail, Anita

AU - Tse, Margaret C.L.

AU - Song, Jin H.

AU - Phuphanich, Surasak

AU - Olson, Jeffrey J.

AU - Sun, Shi Yong

AU - Hao, Chunhai

PY - 2010/6/1

Y1 - 2010/6/1

N2 - To explore the molecular mechanisms by which glioblastomas are resistant to tumour necrosis factor-related apoptosis-inducing ligand (TRAIL), we examined TRAIL signalling pathways in the tumours. TRAIL has four membrane-anchored receptors, death receptor 4/5 (DR4/5) and decoy receptor 1/2 (DcR1/2). Of these receptors, only DR5 was expressed consistently in glioblastoma cell lines and tumour tissues, ruling out the role of DcR1/2 in TRAIL resistance. Upon TRAIL binding, DR5 was homotrimerized and recruited Fas-associated death domain (FADD) and caspase-8 for the assembly of death-inducing signalling complex (DISC) in the lipid rafts of the plasma membrane. In the DISC, caspase-8 was cleaved and initiated apoptosis by cleaving downstream caspases in TRAIL-sensitive glioblastoma cells. In TRAIL-resistant cells, however, DR5-mediated DISC was modified by receptor-interacting protein (RIP), cellular FADD-like interleukin-1β-converting enzyme inhibitory protein (c-FLIP) and phosphoprotein enriched in diabetes or in astrocyte-15 (PED/PEA-15). This DISC modification occurred in the non-raft fractions of the plasma membrane and resulted in the inhibition of caspase-8 cleavage and activation of nuclear factor-κB (NF-κB). Treatment of resistant cells with parthenolide, an inhibitor of inhibitor of κB (I-κB), eliminated TRAIL-induced NF-κB activity but not TRAIL resistance. In contrast, however, targeting of RIP, c-FLIP or PED/PEA-15 with small interfering RNA (siRNA) led to the redistribution of the DISC from non-rafts to lipid rafts and eliminated the inhibition of caspase-8 cleavage and thereby TRAIL resistance. Taken together, this study indicates that the DISC modification by RIP, c-FLIP and PED/PEA-15 is the most upstream event in TRAIL resistance in glioblastomas.

AB - To explore the molecular mechanisms by which glioblastomas are resistant to tumour necrosis factor-related apoptosis-inducing ligand (TRAIL), we examined TRAIL signalling pathways in the tumours. TRAIL has four membrane-anchored receptors, death receptor 4/5 (DR4/5) and decoy receptor 1/2 (DcR1/2). Of these receptors, only DR5 was expressed consistently in glioblastoma cell lines and tumour tissues, ruling out the role of DcR1/2 in TRAIL resistance. Upon TRAIL binding, DR5 was homotrimerized and recruited Fas-associated death domain (FADD) and caspase-8 for the assembly of death-inducing signalling complex (DISC) in the lipid rafts of the plasma membrane. In the DISC, caspase-8 was cleaved and initiated apoptosis by cleaving downstream caspases in TRAIL-sensitive glioblastoma cells. In TRAIL-resistant cells, however, DR5-mediated DISC was modified by receptor-interacting protein (RIP), cellular FADD-like interleukin-1β-converting enzyme inhibitory protein (c-FLIP) and phosphoprotein enriched in diabetes or in astrocyte-15 (PED/PEA-15). This DISC modification occurred in the non-raft fractions of the plasma membrane and resulted in the inhibition of caspase-8 cleavage and activation of nuclear factor-κB (NF-κB). Treatment of resistant cells with parthenolide, an inhibitor of inhibitor of κB (I-κB), eliminated TRAIL-induced NF-κB activity but not TRAIL resistance. In contrast, however, targeting of RIP, c-FLIP or PED/PEA-15 with small interfering RNA (siRNA) led to the redistribution of the DISC from non-rafts to lipid rafts and eliminated the inhibition of caspase-8 cleavage and thereby TRAIL resistance. Taken together, this study indicates that the DISC modification by RIP, c-FLIP and PED/PEA-15 is the most upstream event in TRAIL resistance in glioblastomas.

KW - Apoptosis

KW - Caspase-8

KW - DR5

KW - Glioblastoma

KW - TRAIL

UR - http://www.scopus.com/inward/record.url?scp=77955165505&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955165505&partnerID=8YFLogxK

U2 - 10.1111/j.1582-4934.2009.00777.x

DO - 10.1111/j.1582-4934.2009.00777.x

M3 - Article

VL - 14

SP - 1303

EP - 1317

JO - Journal of Cellular and Molecular Medicine

JF - Journal of Cellular and Molecular Medicine

SN - 1582-1838

IS - 6 A

ER -